US 9809824
CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
granted A61PA61P37/04
Quick answer
US patent 9809824 (CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P37/04